Latest News

Yale Principal Investigators Rong Fan, PhD, Mina L. Xu, MD, Stephanie Halene, MD, and Zongming Ma, PhD, have received an NIH U01 award to establish the Center for Human Lymphoma Spatiotemporal Atlas (HuLymSTA) to construct an atlas of human lymphomas in transformation from indolent to aggressive cancer. In addition, Gisela Gabernet, PhD, Associate Research Scientist in Pathology in the Lab of Steven Kleinstein, PhD, Anthony N. Brady Professor of Pathology, received a NIH U01 grant for her project titled, “Large-scale integrated data analysis of lymphocyte receptor repertoires with workflows.” It is a three-year, $1.5M project.

A gene mutation that causes human immune defects reveals new biology of antibody responses and may open the door to new autoimmune disease treatments, a Yale-led study has found.

The use of AI to measure immune health could lead to precision medicine tools that assess an individual’s current and future health trajectory, a Yale study finds.

One of the largest multiomics analyses to date examines hallmarks associated with COVID-19 severity and mortality, and how these factors interact with one another.

The Yale Pathology Research in Progress series provides students with feedback that helps improve their research projects and presentations.

Scientists have identified a short window early in life during which an antibody that might prevent allergies to peanuts and other foods could become a therapeutic target.

Madeline Mayday, BS, and Noah Yann Lee, BS, were recently awarded prestigious Ruth L. Kirschstein Predoctoral Individual National Research Service Awards (F31) from the National Institutes of Health (NIH).

A new study harnesses big data and bioinformatics to explore how the immune system can fight off the virus in some cases and fails in others.

Kleinstein has made fundamental contributions to immunology through the development and application of innovative computational methods.